PDT Laser System (PDT-635S)

 KR ▼

•   DE
•   JP
•   RU
•   IN
•   FR
•   ES
•   IT

• Category : Medical devices/General Surgery Devices
• Specification: PDT-635S
• Standard : ISO9001, ISO13485
• Description :
• Photodynamic therapy (Photodynamic Therapy, PDT) is a minimally invasive treatment of proliferative diseases of the new model, not only in the treatment of malignant entities achieved encouraging results (United States, Japan, Canada and other countries have been approved to carry out this therapy), and PDT as a new technology, in the treatment of non-neoplastic, proliferative diseases (including Condyloma) demonstrated the unique advantages of the medical profession has been gaining wide attention. The treatment pattern is dominated by laser irradiation to contain a large number of lesions of photosensitive drugs to produce sufficient quantities of single-state oxygen trigger strong photochemical reaction, selective destruction of diseased tissue therapeutic purposes, so a suitable photosensitizer, appropriate excitation System (laser light source) is the treatment of proliferative diseases PDT key. Before the market launch of the first generation of photosensitive drugs and laser light source wavelength 300mW combining to bring the Gospel of patients achieved good clinical treatment. But the first generation of photosensitive drugs need to light a long time, and low exposure to the efficiency of laser power is low, has been gradually increasing number of patients not meet the rapid demands. Market, recently introduced the second generation of the new photosensitive drug 5 amino -4 - Aminolevulinic valerate (5-ALA) and so on. LYPE group Co., Ltd. launched a new large-scale 400mW of power by 635± 5nm semiconductor laser. The light source used for irradiation, can significantly shorten the treatment time to improve the therapeutic effect. Wuhan Lingyun photovoltaic technology is the first semiconductor laser to professionals in laser-based company, a total of eight years since the company obtained patents related to semiconductor laser 20, and adopted the ISO9001, ISO13485 quality system certification and CE certification, product are exported to many countries in Europe and America, is one of the earliest and the most powerful semiconductor laser companies. 1, Mechanism: 635 semi-conductor laser therapeutic apparatus as excitation light source for PDT, the wavelength of 635nm, output power is 400mw, in a 5 - Aminolevulinic acid hydrochloride (5-ALA) for photosensitive drugs PDT course of treatment, through exposure to contain a large number of the lesions photosensitizer to produce sufficient quantities of single-state oxygen triggered strong photochemical reaction, selective destruction of diseased tissue therapeutic purposes. Simple 635nm wavelength laser irradiation on normal tissue without damage. Its effect depends on the lesion PDT cells on the choice of 5-ALA absorption and accumulation. Specific use of photosensitizer in diseased tissue retention characteristics, and give full play to the selective killing effect of PDT, not harm normal tissues. This treatment method is simple, specific, less trauma and less side effects, low cost, with other therapies can not compare the advantages and development prospects. 2, Features: 635 semi-conductor laser therapeutic apparatus is characterized by monochrome laser output is good, simple, intelligent, stable and secure, more importantly, increased power to choose treatment, time is short and quick results. 3, The scope: Products are mainly applied to treatment occurred in different parts of the body vary from person to person papillomavirus infection and mucosal surface of skin infections caused by proliferative diseases, including genital and skin warts, such as condyloma, etc... Its function is mainly the use of the laser light source, a new type of coating photosensitive drugs lesions organizations safe and effective exposure and treatment, so that tissue necrosis lesions off in order to achieve therapeutic effect.